Who are Vinblastine/prednisone's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/vinblastine-prednisone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Vinblastine/prednisone — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vinblastine/prednisone (Vinblastine/prednisone) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vinca alkaloid and corticosteroid. Area: Oncology.

phase 3 Vinca alkaloid and corticosteroid Microtubules and glucocorticoid receptor Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Vinblastine/prednisone (Vinblastine/prednisone) — Baylor College of Medicine. Vinblastine is a vinca alkaloid that inhibits microtubule formation in the mitotic spindle, thereby inducing cell cycle arrest at the metaphase and apoptosis. Prednisone is a corticosteroid that has anti-inflammatory and immunosuppressive properties.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Vinblastine/prednisone TARGET	Vinblastine/prednisone	Baylor College of Medicine	phase 3	Vinca alkaloid and corticosteroid	Microtubules and glucocorticoid receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vinca alkaloid and corticosteroid class)

Baylor College of Medicine · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vinblastine/prednisone — Competitive Intelligence Brief. https://druglandscape.com/ci/vinblastine-prednisone. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing